Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach

Molecular BioSystems

Volumn 12, Issue 3, 2016, Pages 963-972

  Srihari, Sriganesh ^a   Kalimutho, Murugan ^b   Lal, Samir ^c   Singla, Jitin ^d   Patel, Dhaval ^d   Simpson, Peter T ^a,c   Khanna, Kum Kum ^b   Ragan, Mark A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

BIOLOGICAL MODEL; BREAST TUMOR; CANCER GRADING; CANCER STAGING; CLUSTER ANALYSIS; COHORT ANALYSIS; COPY NUMBER VARIATION; FEMALE; GENE REGULATORY NETWORK; GENE SILENCING; GENETICS; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE; METABOLISM; PATHOLOGY; REPRODUCIBILITY; RISK FACTOR; TUMOR GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CLUSTER ANALYSIS; COHORT STUDIES; DNA COPY NUMBER VARIATIONS; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENE REGULATORY NETWORKS; GENES, NEOPLASM; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; MODELS, GENETIC; NEOPLASM GRADING; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; RISK FACTORS; RNA, SMALL INTERFERING;

EID: 84959135276     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c5mb00655d     Document Type: Article

References (45)

1. J. Farley et al., Estimates of cancer incidence and mortality in Europe in 2008 Eur. J. Cancer 2010 46 765 781
2. C. M. Perou et al., Molecular traits of human breast tumours Nature 2000 406 6797 747 752
3. T. Sørlie et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc. Natl. Acad. Sci. U. S. A. 2001 98 19 10869 10874
4. M. Kalimutho K. Parsons et al., Targeted therapies for triple-negative breast cancer: Combating a stubborn disease Trends Pharmacol. Sci. 2015 36 12 822 846
5. G. Ciriello Emerging landscape of oncogenic signatures across human cancers Nat. Genet. 2013 45 1127 1133
6. C. Curtis The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups Nature 2012 486 346 352
7. B. I. Sigbjørnsdottir Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer J. Med. Genet. 2000 37 5 342 347
8. D. G. Holland et al., ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium EMBO Mol. Med. 2011 3 167 180
9. The Cancer Genome Atlas Network Nature 2012 490 61 70
10. R. Shen et al., Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis Bioinformatics 2009 25 2906 2912
11. H. R. Ali et al., Genome-driven integrated classification of breast cancer validated in over 7500 samples Genome Biol. 2014 15 431
12. N. Huang et al., Lessons from a decade of integrating cancer copy number alterations with gene expression profiles Briefings Bioinf. 2012 13 3 305 316
13. A. S. Adler et al., Genetic regulators of large-scale transcriptional signatures in cancer Nat. Genet. 2006 38 421 430
14. H. Ding et al., iGPSe: A visual analytic system for integrative genomic based cancer patient stratification BMC Bioinf. 2014 15 203
15. M. Hofree et al., Network-based stratification of tumor mutations Nat. Methods 2013 10 1108 1115
16. R. Bar-Yehuda S. Even A linear-time approximation algorithm for the weighted vertex cover problem J. Algorithms 1981 2 198 203
17. J. W. Kent et al., The Human Genome Browser at UCSC Genome Res. 2002 12 996 1006
18. M. Lawrence Software for computing and annotating genomic ranges PLoS Comput. Biol. 2013 9 8 e1003118
19. S. Razick et al., iRef Index: a consolidated protein interaction database with provenance BMC Bioinf. 2008 9 405
20. S. Srihari M. A. Ragan Systematic tracking of dysregulated modules identifies novel genes in cancer Bioinformatics 2013 29 12 1553 1561
21. S. Srihari H. W. Leong Employing functional interactions for characterisation and detection of sparse complexes from yeast PPI networks Int. J. Bioinf. Res. Appl. 2012 8 3 286 304
22. L. Hubert P. Arabie Comparing partitions Journal of Classification 1985 2 1 193 218
23. H. Kennecke et al., Metastatic behaviour of breast cancer subtypes J. Clin. Oncol. 2010 28 20 3271 3277
24. C. Liu S. Srihari et al., A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy Nucleic Acids Res. 2014 42 10 6106 6127
25. Y. Gökmen-Polar, Y. Neelamraju, C. P. Goswami, et al., Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer, Mod. Pathol., 2015, 28, 677 685
26. S. A. O'Toole et al., Therapeutic targets in triple-negative breast cancer J. Clin. Pathol. 2013 66 530 542
27. S. Zona et al., FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance Biochim. Biophys. Acta, Gene Regul. Mech. 2014 1839 11 1316 1322
28. Y. Y. Park et al., FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair Carcinogenesis 2012 33 10 1843 1853
29. R. Marcotte et al., Essential gene profiles in breast, pancreatic, and ovarian cancer cells Cancer Discovery 2012 2 2 172 189
30. J. Majka et al., Requirement for ATP by the DNA damage checkpoint clamp loader J. Biol. Chem. 2004 279 20921 20926
31. H. S. Kim S. J. Brill Rfc4 interacts with Rpa1 and is required for both DNA replication and DNA damage checkpoints in Saccharomyces cerevisiae Mol. Cell. Biol. 2001 21 3725 3737
32. V. Ellison B. Stillman Biochemical Characterization of DNA Damage Checkpoint Complexes∗ Clamp Loader and Clamp Complexes with Specificity for 5′ Recessed DNA PLoS Biol. 2003 1 2 e33
33. J. Xiang et al., Levels of human replication factor C4, a clamp loader, correlate with tumor progression and predict the prognosis for colorectal cancer J. Transl. Med. 2014 12 320
34. M. Arai et al., The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells Liver Int. 2009 29 1 55 62
35. P. Shannon et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Res. 2003 13 11 2498 2504
36. C. Yang H. Chen et al., Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer Cancer Gene Ther. 2013 20 117 124
37. M. Halasi A. L. Gartel Targeting FOXM1 in cancer Biochem. Pharmacol. 2013 85 5 644 652
38. S. Cabarcas L. Schramm RNA polymerase III transcription in cancer: the BRF2 connection Mol. Cancer 2011 10 47
39. S. Cabarcas J. Jacob I. Veras L. Schramm Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells BMC Mol. Biol. 2008 9 74
40. W. W. Lockwood R. Chari B. P. Choe K. L. Thu et al., Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma PLoS Med. 2010 7 7 e1000315
41. C. K. Y. Ng L. G. Martelotto A. Gauthier H.-C. Wen et al., Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification Genome Biol. 2015 16 107
42. S. Srihari J. Singla L. Wong M. Ragan. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer Biol. Direct 2015 10 57
43. F. Al-Ejeh P. T. Simpson J. M. Sanus et al., Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer Oncogenesis 2014 3 e100
44. S. A. Forbes, G. Bhamra and S. Bamford, et al., The Catalogue of Somatic Mutations in Cancer (COSMIC), Current Protocols in Human Genetics, 2008, ch. 10-11
45. B. Vogelstein N. Papadopoulos V. E. Velculescu et al., Cancer genome landscapes Science 2013 339 6127 1546 1558